A, P., C, A., A, B., TS, L., & D, M. (2006). NSC 290205-based therapy in murine pancreatic adenocarcinoma PAN02 in combination with adriamycin (ADR). Anticancer research, 26(1A), 243.
Chicago Style (17th ed.) CitationA, Papageorgiou, Andreadis C, Boutis A, Lialiaris TS, and Mouratidou D. "NSC 290205-based Therapy in Murine Pancreatic Adenocarcinoma PAN02 in Combination with Adriamycin (ADR)." Anticancer Research 26, no. 1A (2006): 243.
MLA (9th ed.) CitationA, Papageorgiou, et al. "NSC 290205-based Therapy in Murine Pancreatic Adenocarcinoma PAN02 in Combination with Adriamycin (ADR)." Anticancer Research, vol. 26, no. 1A, 2006, p. 243.
Warning: These citations may not always be 100% accurate.